154 related articles for article (PubMed ID: 6729678)
21. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma.
Meguerditchian AN; Bairati I; Lagacé R; Harel F; Kibrité A
Am J Surg; 2005 Jun; 189(6):707-13. PubMed ID: 15910724
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic tests in the prognosis and course controls in bronchial carcinoma patients.
Dallüge KH; Ziegenbein R
Arch Geschwulstforsch; 1982 May; 52(3):199-202. PubMed ID: 7125855
[TBL] [Abstract][Full Text] [Related]
24. The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma.
Sandock DS; Seftel AD; Resnick MI
J Urol; 1997 Mar; 157(3):798-9. PubMed ID: 9072569
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
28. Repeat hepatectomy for recurrent colorectal liver metastases.
Pessaux P; Lermite E; Brehant O; Tuech JJ; Lorimier G; Arnaud JP
J Surg Oncol; 2006 Jan; 93(1):1-7. PubMed ID: 16353192
[TBL] [Abstract][Full Text] [Related]
29. Hepatic resection for colorectal liver metastases.
Hananel N; Garzon J; Gordon PH
Am Surg; 1995 May; 61(5):444-7. PubMed ID: 7733553
[TBL] [Abstract][Full Text] [Related]
30. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
31. [Multivariate regressive analysis of prognosis of liver metastases from colorectal cancer].
Zhou ZW; Ren JQ; Wan DS; Chen G; Lu ZH; Pan ZZ; Li LR; Wu XJ; Ding PR
Ai Zheng; 2006 Sep; 25(9):1149-52. PubMed ID: 16965660
[TBL] [Abstract][Full Text] [Related]
32. Major hepatic resection reduces the probability of intrahepatic recurrences following resection of colorectal carcinoma liver metastases.
Nagakura S; Shirai Y; Yokoyama N; Wakai T; Suda T; Hatakeyama K
Hepatogastroenterology; 2003; 50(51):779-83. PubMed ID: 12828084
[TBL] [Abstract][Full Text] [Related]
33. [Surgical resection of hepatic metastases of cancers of the colon and rectum].
Nordlinger B; De Sena G; Szawlowski A; Orea Martinez JG; Parc R; Malafosse M; Huguet C
Gastroenterol Clin Biol; 1983 Mar; 7(3):240-3. PubMed ID: 6852411
[TBL] [Abstract][Full Text] [Related]
34. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomas.
Harmenberg U; Koha M; Makiya R; Koshida K; Brismar B; Stigbrand T; Wahren B
Tumour Biol; 1991; 12(4):237-48. PubMed ID: 1871513
[TBL] [Abstract][Full Text] [Related]
36. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Tanaka Y; Masuda T; Mukoyama S; Yasuda S; Tajima T; Makuuchi H; Murayama C
Hepatogastroenterology; 2003; 50(53):1362-6. PubMed ID: 14571738
[TBL] [Abstract][Full Text] [Related]
37. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
38. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
39. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G
Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760
[TBL] [Abstract][Full Text] [Related]
40. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study.
Sjövall A; Järv V; Blomqvist L; Singnomklao T; Cedermark B; Glimelius B; Holm T
Eur J Surg Oncol; 2004 Oct; 30(8):834-41. PubMed ID: 15336728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
